Skip to content
Main Menu
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
Financial Statements-2023
Parent Company Only Financial Statement-2023
Consolidated Financial Statements
-2023
Prev
PREVIOUS
Announcement for the Board meeting date of the Second Quarter of 2024 Financial Report
NEXT
Announcement of the resolution by the BOD for the ex-rights and record date of stock dividends on behalf of major subsidiary, Excelsior Asset Management Co., Ltd.
Next
Investors
Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
